annb0t
Top 20
For the quarter ended December 2024, ResMed (RMD) reported revenue of $1.28 billion, up 10.3% over the same period last year. EPS came in at $2.43, compared to $1.88 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.26 billion, representing a surprise of +1.57%. The company delivered an EPS surprise of +5.65%, with the consensus EPS estimate being $2.30.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with W...
>>> Read more: Compared to Estimates, ResMed (RMD) Q2 Earnings: A Look at Key Metrics
The reported revenue compares to the Zacks Consensus Estimate of $1.26 billion, representing a surprise of +1.57%. The company delivered an EPS surprise of +5.65%, with the consensus EPS estimate being $2.30.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with W...
>>> Read more: Compared to Estimates, ResMed (RMD) Q2 Earnings: A Look at Key Metrics
